We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$52.5B
AUM Growth
-$1.16B
(-2.2%)
Cap. Flow
-$399M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
2,386
New
193
Increased
800
Reduced
1,005
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$161M |
| 2 |
Invivyd
IVVD
|
+$94.7M |
| 3 |
Freeport-McMoran
FCX
|
+$88.6M |
| 4 |
Amgen
AMGN
|
+$87.7M |
| 5 |
Truist Financial
TFC
|
+$83.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$296M |
| 2 |
Pfizer
PFE
|
+$276M |
| 3 |
Cisco
CSCO
|
+$151M |
| 4 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
+$103M |
| 5 |
Evergy
EVRG
|
+$99.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.48% |
| 2 | Technology | 20.59% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Piper Sandler
PIPR
$5.04B
| $183K | ﹤0.01% |
5,300
-608
| -10% | -$20.4K |
|
|
VSTA
1677
DELISTED
Vasta Platform
VSTA
| $183K | ﹤0.01% |
40,000
+10,000
| +33% | +$62.8K |
|
1678
DXP Enterprises
DXPE
$2.85B
| $182K | ﹤0.01% |
6,152
+4,109
| +201% | +$126K |
|
1679
Coherus Oncology
CHRS
$188M
| $179K | ﹤0.01% |
+11,131
| New | +$163K |
|
1680
Caesars Entertainment
CZR
$6.05B
| $178K | ﹤0.01% |
1,588
-1,593
| -50% | -$156K |
|
1681
Healthpeak Properties
DOC
$14B
| $177K | ﹤0.01% |
5,287
-91
| -2% | -$3.22K |
|
1682
Teledyne Technologies
TDY
$27.9B
| $176K | ﹤0.01% |
409
-49
| -11% | -$21.7K |
|
1683
World Kinect Corp
WKC
$1.81B
| $176K | ﹤0.01% |
5,248
-17,054
| -76% | -$546K |
|
1684
Amneal Pharmaceuticals
AMRX
$6.3B
| $175K | ﹤0.01% |
32,704
+5,122
| +19% | +$25.8K |
|
1685
Rockwell Automation
ROK
$46.1B
| $175K | ﹤0.01% |
594
-760
| -56% | -$233K |
|
|
MODV
1686
DELISTED
ModivCare
MODV
| $174K | ﹤0.01% |
957
-77
| -7% | -$13.7K |
|
1687
SiriusXM
SIRI
$9.63B
| $174K | ﹤0.01% |
2,847
+43
| +2% | +$2.7K |
|
1688
Teleflex
TFX
$5.42B
| $174K | ﹤0.01% |
463
-2
| -0.4% | -$779 |
|
1689
NIO
NIO
$8.97B
| $173K | ﹤0.01% |
4,864
-1,760
| -27% | -$72.3K |
|
|
CHNG
1690
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $173K | ﹤0.01% |
8,242
-5,460
| -40% | -$119K |
|
1691
Kforce
KFRC
$935M
| $172K | ﹤0.01% |
2,872
-15
| -0.5% | -$904 |
|
|
TVRD
1692
Tvardi Therapeutics
TVRD
$23.1M
| $172K | ﹤0.01% |
309
-49
| -14% | -$24.6K |
|
1693
Akamai
AKAM
$15B
| $168K | ﹤0.01% |
1,608
-104,739
| -98% | -$12M |
|
1694
Worthington Enterprises
WOR
$2.88B
| $167K | ﹤0.01% |
5,132
-7,210
| -58% | -$260K |
|
|
AGNT
1695
AGNT Inc
AGNT
$652M
| $166K | ﹤0.01% |
4,183
+1,255
| +43% | +$53.7K |
|
1696
LCI Industries
LCII
$2.12B
| $166K | ﹤0.01% |
1,231
-42
| -3% | -$5.8K |
|
1697
Safety Insurance
SAFT
$1.52B
| $166K | ﹤0.01% |
2,094
-16
| -0.8% | -$1.26K |
|
1698
Welltower
WELL
$169B
| $166K | ﹤0.01% |
2,020
-2,158
| -52% | -$185K |
|
|
ETWO
1699
DELISTED
E2open Parent Holdings
ETWO
| $165K | ﹤0.01% |
+14,561
| New | +$163K |
|
|
K
1700
DELISTED
Kellanova
K
| $165K | ﹤0.01% |
+2,747
| New | +$165K |
|
Similar funds
Federated Hermes's Q3 2021 Portfolio in Review
As of Q3 2021, Federated Hermes held 2,386 positions worth $52.5B, down 2.2% from $53.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Federated Hermes's Q3 2021 filing shows 193 new, 800 increased, 1,005 reduced and 184 closed positions. Its largest new stake was GXO Logistics: 2,051,695 shares worth $161M. The largest sale was Moderna, an estimated $296M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2021 buy was GXO Logistics: 2,051,695 shares worth $161M.
- Federated Hermes added most to Freeport-McMoran in Q3 2021, an estimated $88.6M increase.
- Federated Hermes's biggest Q3 2021 reduction was Moderna, cutting an estimated $296M.
- Federated Hermes fully exited Translate Bio, Inc. Common Stock in Q3 2021, selling an estimated $103M.
- Federated Hermes's ten largest holdings make up 12% of its $52.5B portfolio in Q3 2021.
- Federated Hermes opened 193 new positions and closed 184 in Q3 2021.
- Federated Hermes's portfolio value fell 2.2% quarter-over-quarter to $52.5B.
Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.